Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase II data reported for S*BIO's SB-939

Nov. 21, 2011

FDA approves Jakafi for patients with myelofibrosis

Nov. 18, 2011

Promising preclinical results presented for LDK-378

Nov. 18, 2011

EZN-3042 administered with docetaxel in phase I study

Nov. 18, 2011

Sunshine Biopharma completes preclinical studies of Adva-27a

Nov. 18, 2011

Bristol-Myers Squib seeks approval of new indication for Taxol in Japan

Nov. 17, 2011

PharmaGap starts animal efficacy study of GAP-107B8

Nov. 17, 2011

Phase I LG-631 gene therapy trial initiated for brain cancer

Nov. 17, 2011

European Commission approves Vectibix for expanded indications

Nov. 16, 2011

SymBio announces plan for new study of SyB L-0501 in multiple myeloma

Nov. 16, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...